title: [Chemoradioresistance of the female reproductive system cancer--can local laser hyperthermia contribute to its overcoming?].
abstract: There is presented the method of local laser hyperthermia on the domestic nanotechnological optic-fiber device LAZON-FT integrated into the program of brachytherapy for tumors of the female reproductive system. This is a universal radiosensibilizator that demonstrates the acceleration of tumor regression also during local and systemic chemotherapy--tumor regression at 50-705 in such conditions permits recommend it in locally advanced cervical and endometrial cancer as well as cancer of the vulva and vagina in the frames of combined use with brachytherapy and chemotherapy.
authors.forename: V A
authors.initials: VA
authors.lastname: Titova
authors.forename: L N
authors.initials: LN
authors.lastname: Shevchenko
authors.forename: Yu M
authors.initials: YM
authors.lastname: Kreinina
authors.forename: V Yu
authors.initials: VY
authors.lastname: Petrovsky
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001918:Brachytherapy; D059248:Chemoradiotherapy; D003131:Combined Modality Therapy / Q000379:methods; D019008:Drug Resistance, Neoplasm; D016889:Endometrial Neoplasms / Q000628:therapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000473:pathology / Q000628:therapy*; D006801:Humans; D006979:Hyperthermia, Induced / Q000295:instrumentation / Q000379:methods; D007834:Lasers; D008875:Middle Aged; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000628:therapy; D014625:Vaginal Neoplasms / Q000628:therapy; D014846:Vulvar Neoplasms / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents